Who has invested in Altamira Therapeutics?

No investors are named on the public record for Altamira Therapeutics yet.

Altamira Therapeutics Funding: $4M Raised, Post-IPO equity

Altamira Therapeutics funding overview

Altamira Therapeutics is based in Hamilton, Bermuda. Altamira Therapeutics has raised $4M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Post-IPO equity announced in January 2024. The round record for Altamira Therapeutics runs through 2024; nothing later has been disclosed.

Altamira Therapeutics at a glance

Total raised: $4M
Latest round: Post-IPO equity
Latest round date: January 2024
Headquarters: Hamilton, Bermuda

Frequently asked about Altamira Therapeutics funding

How much has Altamira Therapeutics raised?: Altamira Therapeutics has raised $4M in total disclosed funding across the rounds on record.
Who has invested in Altamira Therapeutics?: No investors are named on the public record for Altamira Therapeutics yet.
What was the latest Altamira Therapeutics funding round?: The most recent disclosed round is a Post-IPO equity, announced in January 2024.
Where is Altamira Therapeutics based?: Altamira Therapeutics is based in Hamilton, Bermuda.
When did Altamira Therapeutics last raise?: The last disclosed Altamira Therapeutics round closed in January 2024 at Post-IPO equity.

Altamira Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hamilton below to benchmark round size and investor mix.

Altamira Therapeutics Funding: $4M Raised, Post-IPO equity

Altamira Therapeutics funding overview

Altamira Therapeutics at a glance

Frequently asked about Altamira Therapeutics funding

Companies related to Altamira Therapeutics (40)

Browse related funding lists (2)